These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 27769564

  • 1. In vivo anti-inflammatory activities of novel cytokine IL-38 in Murphy Roths Large (MRL)/lpr mice.
    Chu M, Tam LS, Zhu J, Jiao D, Liu H, Cai Z, Dong J, Kai Lam CW, Wong CK.
    Immunobiology; 2017 Mar; 222(3):483-493. PubMed ID: 27769564
    [Abstract] [Full Text] [Related]

  • 2. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
    Cai Z, Wong CK, Dong J, Chu M, Jiao D, Kam NW, Lam CW, Tam LS.
    Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
    [Abstract] [Full Text] [Related]

  • 3. Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice.
    Yan SX, Deng XM, Wang QT, Sun XJ, Wei W.
    Acta Pharmacol Sin; 2015 Nov; 36(11):1367-76. PubMed ID: 26456588
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
    Hu L, Hu J, Chen L, Zhang Y, Wang Q, Yang X.
    Front Immunol; 2021 Nov; 12():584414. PubMed ID: 33717066
    [Abstract] [Full Text] [Related]

  • 5. IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice.
    Rankin AL, Guay H, Herber D, Bertino SA, Duzanski TA, Carrier Y, Keegan S, Senices M, Stedman N, Ryan M, Bloom L, Medley Q, Collins M, Nickerson-Nutter C, Craft J, Young D, Dunussi-Joannopoulos K.
    J Immunol; 2012 Feb 15; 188(4):1656-67. PubMed ID: 22231702
    [Abstract] [Full Text] [Related]

  • 6. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
    Yao L, Chen HP, Ma Q.
    Immunol Lett; 2014 Sep 15; 161(1):76-80. PubMed ID: 24837470
    [Abstract] [Full Text] [Related]

  • 7. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J, Fan H, Li F, Li X, Dong G, Gong W, Song Y, Liu F, Hua C, Tan R, Dou H, Hou Y.
    Immunol Lett; 2015 Dec 15; 168(2):355-65. PubMed ID: 26545567
    [Abstract] [Full Text] [Related]

  • 8. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H, Relle M, Menke J, Brochhausen C, Jones SA, Topley N, Galle PR, Schwarting A.
    J Rheumatol; 2010 Jan 15; 37(1):60-70. PubMed ID: 19955044
    [Abstract] [Full Text] [Related]

  • 9. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice.
    Chuan W, Wu-qing W, Zhu-wen Y, Zuo L.
    Lupus; 2014 Sep 15; 23(10):994-1005. PubMed ID: 24756437
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
    Yang J, Li Q, Yang X, Li M.
    Mol Med; 2015 Apr 15; 21(1):364-70. PubMed ID: 25902303
    [Abstract] [Full Text] [Related]

  • 11. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T, Paust HJ, Krebs CF, Turner JE, Kaffke A, Bennstein SB, Koyro T, Peters A, Velden J, Hünemörder S, Haag F, Steinmetz OM, Mittrücker HW, Stahl RA, Panzer U.
    Arthritis Rheumatol; 2015 Feb 15; 67(2):475-87. PubMed ID: 25385550
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ, Li H, Jiang B, Nandakumar KS, Liu KF, Liu LX, Yu XC, Tan HJ, Zhou C.
    Phytomedicine; 2019 Sep 15; 62():152965. PubMed ID: 31129432
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-25 is upregulated in patients with systemic lupus erythematosus and ameliorates murine lupus by inhibiting inflammatory cytokine production.
    Li Y, Wang R, Liu S, Liu J, Pan W, Li F, Li J, Meng D.
    Int Immunopharmacol; 2019 Sep 15; 74():105680. PubMed ID: 31200339
    [Abstract] [Full Text] [Related]

  • 14. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.
    J Immunol; 2011 Sep 15; 187(6):3413-21. PubMed ID: 21849682
    [Abstract] [Full Text] [Related]

  • 15. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K, Matejuk A, Xu Y, Beardall M, Chen C.
    J Immunol; 2012 Apr 15; 188(8):3628-38. PubMed ID: 22407922
    [Abstract] [Full Text] [Related]

  • 16. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
    Liao W, Zheng H, Wu S, Zhang Y, Wang W, Zhang Z, Zhou C, Wu H, Min J.
    Am J Nephrol; 2017 Apr 15; 46(5):371-379. PubMed ID: 29069649
    [Abstract] [Full Text] [Related]

  • 17. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U.
    J Immunol; 2009 Oct 01; 183(7):4693-704. PubMed ID: 19734217
    [Abstract] [Full Text] [Related]

  • 18. CD4(+)B220(+)TCRγδ(+) T cells produce IL-17 in lupus-prone MRL/lpr mice.
    Qiu F, Li T, Zhang K, Wan J, Qi X.
    Int Immunopharmacol; 2016 Sep 01; 38():31-9. PubMed ID: 27235595
    [Abstract] [Full Text] [Related]

  • 19. (5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/lpr mice by preventing infiltration of immune cells.
    Zhang LY, Li H, Wu YW, Cheng L, Yan YX, Yang XQ, Zhu FH, He SJ, Tang W, Zuo JP.
    Am J Physiol Renal Physiol; 2017 Apr 01; 312(4):F769-F777. PubMed ID: 28100505
    [Abstract] [Full Text] [Related]

  • 20. Cytokine gene expression in the MRL/lpr model of lupus nephritis.
    Lemay S, Mao C, Singh AK.
    Kidney Int; 1996 Jul 01; 50(1):85-93. PubMed ID: 8807576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.